School of Health Sciences, University of Tasmania, Launceston, 7250, TAS, Australia.
Department of Molecular Biosciences & Bioengineering, University of Hawaii, Honolulu, HI, USA.
BMC Complement Altern Med. 2017 Jan 3;17(1):2. doi: 10.1186/s12906-016-1522-1.
Bitter Melon (BM) has been used as a functional food in traditional Chinese and Indian medicine for many generations and has gained a great deal of attention due to its apparent benefits in moderating some of the pathogenic processes in a variety of inflammatory conditions. BM extract (BME) has been shown to possess strong anti-oxidant properties. In addition, it can ameliorate oxidative stress and potentially ER stress. There is increasing evidence that oxidative and ER stress are major contributors for intestinal secretory cell dysfunction which leads to local inflammation and disease pathogenesis that are hallmarks of inflammatory bowel diseases (IBD). Hence, the search for potential therapeutics against ER stress and oxidative stress in intestinal epithelial secretory cells may provide valuable resources for the management of IBD. The aim of the present study was to investigate the effects of BME in ameliorating ER stress in colonic epithelial cells.
Human colonic adenocarcinoma LS174T cells were used for the assessment of BME effects on colonic epithelial cells in vitro. Cell viability was assessed using trypan blue exclusion and the effect of BME in ameliorating tunicamycin (TM)-induced ER stress was determined by analysing the mRNA expression of the common ER stress markers; ATF6, XBP1, GRP78, CHOP and PERK by quantitative RT-PCR and GRP78 and CHOP by western blot.
In the absence of ER stress, BME exhibited no cell toxicity up to 2.0% w/v and no significant effect on the basal mRNA expression of ER stress markers in LS174T cells. In contrast, pre-treatment of LS174T cells with BME followed by induction of ER stress resulted in a significant decrease in mRNA expression of ATF6, XBP1, GRP78, CHOP and PERK and protein expression of GRP78 and CHOP. Co-treatment during induction of ER stress and post- treatment following induction of ER Stress in LS174T cells resulted in a lower but still significant reduction in mRNA expression levels of most ER stress markers.
This is one of the first studies demonstrating the efficacy of BME in reducing expression of ER stress markers in colonic epithelial cells suggesting the potential of BME as a dietary intervention in ameliorating ER stress and oxidation in IBD. Interestingly, while the most significant effect was seen with pre-treatment of cells with BME there was a reduced but still significant effect when co-treated or even post-treated. This suggests that BME may even be effective in modulating ER stress in the face of an existing cell stress environment.
苦瓜(BM)作为一种功能性食品,在中国和印度传统医学中已被使用了几代人,由于其在调节多种炎症条件下的一些致病过程方面的明显益处,引起了广泛关注。苦瓜提取物(BME)已被证明具有很强的抗氧化特性。此外,它可以改善氧化应激和潜在的内质网应激。越来越多的证据表明,氧化应激和内质网应激是肠道分泌细胞功能障碍的主要原因,而肠道分泌细胞功能障碍会导致局部炎症和疾病发生,这是炎症性肠病(IBD)的标志。因此,寻找针对肠道上皮细胞分泌细胞内质网应激和氧化应激的潜在治疗方法,可能为 IBD 的管理提供有价值的资源。本研究旨在探讨 BME 改善结肠上皮细胞内质网应激的作用。
使用人结肠腺癌 LS174T 细胞评估 BME 对体外结肠上皮细胞的作用。使用台盼蓝排除法评估细胞活力,并通过定量 RT-PCR 分析共同内质网应激标志物 ATF6、XBP1、GRP78、CHOP 和 PERK 的 mRNA 表达,以及通过 Western blot 分析 GRP78 和 CHOP,来确定 BME 改善衣霉素(TM)诱导的内质网应激的作用。
在没有内质网应激的情况下,BME 高达 2.0%(w/v)时没有显示出细胞毒性,并且对 LS174T 细胞中内质网应激标志物的基础 mRNA 表达没有显著影响。相比之下,用 BME 预处理 LS174T 细胞,然后诱导内质网应激,导致 ATF6、XBP1、GRP78、CHOP 和 PERK 的 mRNA 表达以及 GRP78 和 CHOP 的蛋白表达显著下降。在 LS174T 细胞诱导内质网应激时进行共同处理,并在诱导内质网应激后进行后处理,导致大多数内质网应激标志物的 mRNA 表达水平仍显著降低。
这是第一项证明 BME 降低结肠上皮细胞内质网应激标志物表达的功效的研究之一,表明 BME 作为一种饮食干预措施,在改善 IBD 中的内质网应激和氧化应激方面具有潜在作用。有趣的是,虽然细胞用 BME 预处理的效果最显著,但当共同处理甚至后处理时,效果仍然显著降低。这表明,即使在存在细胞应激环境的情况下,BME 也可能对调节内质网应激有效。